FDA approves Farydak for treatment of multiple myeloma
On February 23, the U.S. Food and Drug Administration (FDA) approved Farydak (panobinostat) for the treatment of patients with multiple…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.